Skinvisible, Inc. (SKVI) — 10-Q Filings
All 10-Q filings from Skinvisible, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Skinvisible's Cash Dries Up Amidst Mounting Losses, Going Concern Warning Issued
— Nov 13, 2025 Risk: high
SKINVISIBLE, INC. (SKVI) reported a net loss of $805,677 for the nine months ended September 30, 2025, a slight improvement from the $880,425 net loss in the pr -
Skinvisible's Cash Dries Up Amidst Mounting Liabilities
— Aug 13, 2025 Risk: high
SKINVISIBLE, INC. (SKVI) reported a net loss of $555,432 for the six months ended June 30, 2025, a 6.47% improvement from the $593,821 net loss in the prior-yea -
Skinvisible, Inc. Files Q1 2025 10-Q
— May 14, 2025 Risk: medium
Skinvisible, Inc. filed its 10-Q for the period ending March 31, 2025. The company, operating in the pharmaceutical preparations sector, is based in Las Vegas, -
Skinvisible, Inc. Files Q3 2024 10-Q
— Nov 19, 2024 Risk: medium
Skinvisible, Inc. filed its 10-Q for the period ending September 30, 2024. The company, operating in pharmaceutical preparations, reported financial data for Q3 -
Skinvisible, Inc. Files Q2 2024 10-Q
— Aug 15, 2024 Risk: medium
Skinvisible, Inc. filed its 10-Q for the period ending June 30, 2024. The company, operating in the pharmaceutical preparations sector, is based in Las Vegas, N -
Skinvisible, Inc. Files 10-Q for Period Ending March 31, 2024
— May 15, 2024 Risk: low
SKINVISIBLE, INC. (SKVI) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Skinvisible, Inc. filed its quarterly report (10-Q) for the period ending
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX